EUVIMED · CrossrefZeitschrift
International Journal of Oncology
ISSN 1019-6439 · Spandidos Publications
Neueste Artikel
CRISPR opens the door to targeted therapy against glioblastoma (Review)
PRMT1 blockade reverts resistance to KRAS (G12C) inhibition through modulating ferroptosis signalling
[Expression of Concern] Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5‑fluorouracil treatment
Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)
PLD2 fuels 5‑fluorouracil resistance in colorectal cancer: Hypoxic hijacking of autophagy unveils a novel therapeutic vulnerability
[Corrigendum] ETS‑1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer
Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review)
Comprehensive landscape and future perspectives of PIWI‑interacting RNAs in cancer (Review)
Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review)
Nucleocytoplasmic transport in gynaecological cancer: From mechanisms to therapeutic potential (Review)
cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review)
Regulatory T cells in lung adenocarcinoma: Mechanisms of immune escape, prognostic significance and therapeutic opportunities (Review)
Eomesodermin in renal cell carcinoma: Epigenetic and immune crosstalk driving tumor progression (Review)
E3 ubiquitin ligase MAGI3‑mediated TAZ ubiquitination suppresses the non‑small cell lung cancer occurrence and development by targeting the Wnt pathway
Dendritic cell‑based vaccines for colorectal cancer: Mechanisms, clinical progress and future directions (Review)
Stress‑induced catecholamines attenuate sorafenib efficacy by inhibiting ferroptosis in β2‑adrenergic receptor positive renal cell carcinoma
Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review)
Role and underlying mechanisms of miR‑200 family in breast cancer (Review)
Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)
c‑Myc‑regulated RPLP0 via the ROS‑mediated JAK2/STAT3 positive feedback loop facilitates hepatocellular carcinoma malignancy progression
The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review)
Targeting ferroptosis in Helicobacter pylori ‑associated gastric cancer development: From molecular mechanisms to application prospects (Review)
Nanoparticle‑based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)
MicroRNA‑21: A potential therapeutic target in lung cancer (Review)
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)
Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review)
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)
Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review)
AGTR1 potentiates the chemotherapeutic efficacy of cisplatin in esophageal carcinoma through elevation of intracellular Ca 2+ and induction of apoptosis
Jahrgänge
2026 · 702025 · 1272024 · 1092023 · 1352022 · 1722021 · 1352020 · 2122019 · 2852018 · 4342017 · 4722016 · 5442015 · 5272014 · 5222013 · 4722012 · 3852011 · 4432010 · 3232009 · 3412008 · 1662007 · 3352006 · 3512005 · 3492004 · 3742003 · 3682002 · 3582001 · 3512000 · 3121999 · 3141998 · 3651997 · 3571996 · 3411995 · 3711994 · 3751993 · 3381992 · 328
EUVIMED